Clinical Trial Update: A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports that recruitment is ongoing for a Phase 1/2 study evaluating the safety of OpCT-001 in adults with primary photoreceptor dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cone Rod Dystrophy
• Cone-rod Disease
• Inherited Retinal Disease
• Photoreceptor Disease
• Retinal Degeneration
• Retinitis Pigmentosa
• Rod-cone Dystrophy
• Usher Syndrome

Drugs mentioned

• OpCT-001

Snippet

Sponsor: BlueRock Therapeutics | Conditions: Primary Photoreceptor Disease, Retinitis Pigmentosa (RP) | Phase 1, Phase 2 | Status: RECRUITING